Leandro Francisco Pippa

6PUBLICATIONS
18CO-AUTHORS
Clinical pharmacology and therapeuticsPharmacogenomicsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 27, 2025
Model-Informed Dose Optimization of Spironolactone in Neonates and Infants.

Amira Soliman, Leandro F Pippa, Jana Lass

|Jun 26, 2024
Impact of obesity and roux-en-Y gastric bypass on the pharmacokinetics of (R)- and (S)-omeprazole and intragastric pH.

Leandro F Pippa, Valvanera Vozmediano, Lieke Mitrov-Winkelmolen

|Apr 18, 2023
Effect of Chronic Hepatitis C on the Activity of the Membrane Transporters P-gp and OATP1B1/BCRP on Patients With Different Stages of Hepatic Fibrosis.

Leandro Francisco Pippa, Carolina Pinto Vieira, Juciene Aparecida Caris

|Nov 26, 2022
Pharmacokinetics of Carboplatin in Combination with Low-Dose Cyclophosphamide in Female Dogs with Mammary Carcinoma.

Marília Carneiro Machado, Priscila Akemi Yamamoto, Leandro Francisco Pippa

|Mar 19, 2021
Clinical treatment for hepatitis C reverses CYP2C19 inhibition.

Leandro Francisco Pippa, Carolina Pinto Vieira, Juciene Aparecida Caris

|May 29, 2020
Systemic Lupus Erythematosus Activity Affects the Sinusoidal Uptake Transporter OATP1B1 Evaluated by the Pharmacokinetics of Atorvastatin.

Roberta Natália Cestari, Renê Donizeti Ribeiro de Oliveira, Flávio Falcão Lima de Souza

Pageof 1

Frequent Collaborators

3 joint publications

Natalia Valadares de Moraes

3 joint publications

Vera Lucia Lanchote

2 joint publications

Valvanera Vozmediano

2 joint publications

Amira Soliman